AB

Arup Barman

Active Director Director DIN 09176316
DIN 09176316 First appointment May 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Arup Barman

Data last updated:

Arup Barman is a Director at Joy Shrishyam Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Joy Shrishyam Pharmaceuticals Private Limited reported revenue of ₹1.36 Cr (FY 2025).

DIN 09176316
Primary Designation Director
Industry Pharma
First Appointment 17 May 2021
Oldest Company Age 5 yrs
Largest company Joy Shrishyam Pharmaceuticals Private Limited · ₹1.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20212021₹1.36 Cr (FY 2025)Active

Board colleagues of Arup Barman

Directorship timeline

Open interactive timeline →
Joy Shrishyam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arup Barman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arup Barman

Arup Barman currently holds 1 directorship: Joy Shrishyam Pharmaceuticals Private Limited (Director, since 17 May 2021, revenue ₹1.36 Cr (FY 2025)).

Arup Barman was first appointed on 17 May 2021 as Director at Joy Shrishyam Pharmaceuticals Private Limited.

The current boards of Arup Barman's companies include Shyamal Kumar Tunga (Joy Shrishyam Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available